News
StockStory.org on MSN8d
10x Genomics’s (NASDAQ:TXG) Q1: Strong Sales But Quarterly Revenue Guidance Significantly Misses ExpectationsBiotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results , with sales up 9.8% year on year to $154.9 million. On ...
StockStory.org on MSN9d
10x Genomics (TXG) Reports Q1: Everything You Need To Know Ahead Of EarningsBiotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results tomorrow after the bell. Here’s what investors ...
Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 9.8% year on year to $154.9 million. On the other hand, next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results